{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:06:27Z","timestamp":1790100387259,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Disease Control and Prevention Agency","doi-asserted-by":"publisher","award":["2019-ER5502-00"],"award-info":[{"award-number":["2019-ER5502-00"]}],"id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-024-02491-y","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T09:02:31Z","timestamp":1726477351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prime-boost immunization with inactivated human adenovirus type 55 combined with an adjuvant enhances neutralizing antibody responses in mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Sang Hwan","family":"Seo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Im","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohee","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taesoo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Hwan","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"6","key":"2491_CR1","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1055\/s-0041-1733802","volume":"42","author":"JP Lynch","year":"2021","unstructured":"Lynch JP 3rd, Kajon AE, Adenovirus. Epidemiology, global spread of Novel types, and Approach to Treatment. Semin Respir Crit Care Med. 2021;42(6):800\u201321.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"2491_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1128\/JCM.01694-09","volume":"48","author":"MP Walsh","year":"2010","unstructured":"Walsh MP, Seto J, Jones MS, Chodosh J, Xu W, Seto D. Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol. 2010;48(3):991\u20133.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2491_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3201\/eid2607.191707","volume":"26","author":"J Hang","year":"2020","unstructured":"Hang J, Kajon AE, Graf PCF, Berry IM, Yang Y, Sanborn MA, et al. Human adenovirus type 55 distribution, Regional Persistence, and genetic variability. Emerg Infect Dis. 2020;26(7):1497\u2013505.","journal-title":"Emerg Infect Dis"},{"key":"2491_CR4","doi-asserted-by":"publisher","first-page":"1002052","DOI":"10.3389\/fped.2022.1002052","volume":"10","author":"D Zhang","year":"2022","unstructured":"Zhang D, Chen Y, Shi T, Fan H, Tian X, Zhou R, et al. Severe pneumonia caused by human adenovirus type 55 in children. Front Pediatr. 2022;10:1002052.","journal-title":"Front Pediatr"},{"issue":"2","key":"2491_CR5","doi-asserted-by":"publisher","first-page":"e0011151","DOI":"10.1371\/journal.pntd.0011151","volume":"17","author":"MC Liu","year":"2023","unstructured":"Liu MC, Xu Q, Li TT, Wang T, Jiang BG, Lv CL, et al. Prevalence of human infection with respiratory adenovirus in China: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2023;17(2):e0011151.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2491_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3904\/kjim.2019.092","volume":"36","author":"JH Ko","year":"2021","unstructured":"Ko JH, Woo HT, Oh HS, Moon SM, Choi JY, Lim JU, et al. Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018. Korean J Intern Med. 2021;36(1):205\u201313.","journal-title":"Korean J Intern Med"},{"issue":"6","key":"2491_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3201\/eid2306.161848","volume":"23","author":"H Yoo","year":"2017","unstructured":"Yoo H, Gu SH, Jung J, Song DH, Yoon C, Hong DJ, et al. Febrile respiratory illness Associated with Human Adenovirus Type 55 in South Korea Military, 2014\u20132016. Emerg Infect Dis. 2017;23(6):1016\u201320.","journal-title":"Emerg Infect Dis"},{"key":"2491_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jcv.2016.03.002","volume":"78","author":"M Salama","year":"2016","unstructured":"Salama M, Amitai Z, Amir N, Gottesman-Yekutieli T, Sherbany H, Drori Y, et al. Outbreak of adenovirus type 55 infection in Israel. J Clin Virol. 2016;78:31\u20135.","journal-title":"J Clin Virol"},{"issue":"1","key":"2491_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12879-018-3520-z","volume":"18","author":"L Xu","year":"2018","unstructured":"Xu L, Liu J, Liu C, Duan Y, Zhu Y, Xu B, et al. Case-control study of the epidemiological and clinical features of human adenovirus 55 and human adenovirus 7 infection in children with acute lower respiratory tract infections in Beijing, China, 2008\u20132013. BMC Infect Dis. 2018;18(1):634.","journal-title":"BMC Infect Dis"},{"issue":"22","key":"2491_CR10","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.1128\/JVI.02225-12","volume":"86","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Seto D, Cao B, Zhao S, Wan C. Genome sequence of human adenovirus type 55, a re-emergent acute respiratory disease pathogen in China. J Virol. 2012;86(22):12441\u20132.","journal-title":"J Virol"},{"issue":"11","key":"2491_CR11","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3201\/eid2211.160728","volume":"22","author":"J Lafolie","year":"2016","unstructured":"Lafolie J, Mirand A, Salmona M, Lautrette A, Archimbaud C, Brebion A, et al. Severe Pneumonia Associated with Adenovirus Type 55 infection, France, 2014. Emerg Infect Dis. 2016;22(11):2012\u20134.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2491_CR12","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1128\/JCM.01928-09","volume":"48","author":"AE Kajon","year":"2010","unstructured":"Kajon AE, Dickson LM, Metzgar D, Houng HS, Lee V, Tan BH. Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP. J Clin Microbiol. 2010;48(4):1438\u201341.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2491_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12879-020-05258-2","volume":"20","author":"G Lu","year":"2020","unstructured":"Lu G, Peng X, Li R, Liu Y, Wu Z, Wang X, et al. An outbreak of acute respiratory infection at a training base in Beijing, China due to human adenovirus type B55. BMC Infect Dis. 2020;20(1):537.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2491_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1378\/chest.13-1186","volume":"145","author":"B Cao","year":"2014","unstructured":"Cao B, Huang GH, Pu ZH, Qu JX, Yu XM, Zhu Z, et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014;145(1):79\u201386.","journal-title":"Chest"},{"issue":"5","key":"2491_CR15","doi-asserted-by":"publisher","first-page":"e0020923","DOI":"10.1128\/jvi.00209-23","volume":"97","author":"S Zhao","year":"2023","unstructured":"Zhao S, Wu X, Tan Z, Ren Y, Li L, Ou J, et al. Generation of human embryonic stem cell-derived lung organoids for modeling infection and replication differences between human adenovirus types 3 and 55 and evaluating potential antiviral drugs. J Virol. 2023;97(5):e0020923.","journal-title":"J Virol"},{"key":"2491_CR16","doi-asserted-by":"crossref","unstructured":"Zhang Q, Zhou Z, Fan Y, Liu T, Guo Y, Li X, et al. Higher affinities of fibers with cell receptors increase the infection capacity and virulence of human adenovirus type 7 and type 55 compared to type 3. Microbiol Spectr. 2024;12(1):e0109023.","DOI":"10.1128\/spectrum.01090-23"},{"issue":"3","key":"2491_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/irv.12232","volume":"8","author":"QB Lu","year":"2014","unstructured":"Lu QB, Tong YG, Wo Y, Wang HY, Liu EM, Gray GC, et al. Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009\u20132012. Influenza Other Respir Viruses. 2014;8(3):302\u20138.","journal-title":"Influenza Other Respir Viruses"},{"issue":"7","key":"2491_CR18","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3201\/eid2407.171222","volume":"24","author":"JY Heo","year":"2018","unstructured":"Heo JY, Noh JY, Jeong HW, Choe KW, Song JY, Kim WJ, et al. Molecular Epidemiology of Human Adenovirus-Associated Febrile respiratory illness in soldiers, South Korea(1). Emerg Infect Dis. 2018;24(7):1221\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"2491_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3346\/jkms.2017.32.2.287","volume":"32","author":"H Yoon","year":"2017","unstructured":"Yoon H, Jhun BW, Kim H, Yoo H, Park SB. Characteristics of Adenovirus Pneumonia in Korean Military Personnel, 2012\u20132016. J Korean Med Sci. 2017;32(2):287\u201395.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"2491_CR20","doi-asserted-by":"publisher","first-page":"e0170592","DOI":"10.1371\/journal.pone.0170592","volume":"12","author":"JY Park","year":"2017","unstructured":"Park JY, Kim BJ, Lee EJ, Park KS, Park HS, Jung SS, et al. Clinical features and courses of Adenovirus Pneumonia in healthy young adults during an outbreak among Korean Military Personnel. PLoS ONE. 2017;12(1):e0170592.","journal-title":"PLoS ONE"},{"issue":"9","key":"2491_CR21","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00705-016-2949-x","volume":"161","author":"Y Dongliu","year":"2016","unstructured":"Dongliu Y, Guoliang Y, Haocheng X, Shuaijia Q, Li B, Yanglei J. Outbreak of acute febrile respiratory illness caused by human adenovirus B P14H11F14 in a military training camp in Shandong China. Arch Virol. 2016;161(9):2481\u20139.","journal-title":"Arch Virol"},{"key":"2491_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijid.2014.06.019","volume":"28","author":"X Li","year":"2014","unstructured":"Li X, Kong M, Su X, Zou M, Guo L, Dong X, et al. An outbreak of acute respiratory disease in China caused by human adenovirus type B55 in a physical training facility. Int J Infect Dis. 2014;28:117\u201322.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"2491_CR23","doi-asserted-by":"publisher","first-page":"e0160777","DOI":"10.1371\/journal.pone.0160777","volume":"11","author":"L Gu","year":"2016","unstructured":"Gu L, Qu J, Sun B, Yu X, Li H, Cao B. Sustained viremia and high viral load in respiratory tract secretions are predictors for death in Immunocompetent adults with Adenovirus Pneumonia. PLoS ONE. 2016;11(8):e0160777.","journal-title":"PLoS ONE"},{"issue":"1","key":"2491_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/23744235.2015.1055585","volume":"48","author":"SY Zhang","year":"2016","unstructured":"Zhang SY, Luo YP, Huang DD, Fan H, Lu QB, Wo Y, et al. Fatal pneumonia cases caused by human adenovirus 55 in immunocompetent adults. Infect Dis (Lond). 2016;48(1):40\u20137.","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"2491_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/oxfordjournals.aje.a121499","volume":"97","author":"BA Dudding","year":"1973","unstructured":"Dudding BA, Top FH Jr., Winter PE, Buescher EL, Lamson TH, Leibovitz A. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966\u20131971. Am J Epidemiol. 1973;97(3):187\u201398.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"2491_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1086\/522969","volume":"196","author":"LN Binn","year":"2007","unstructured":"Binn LN, Sanchez JL, Gaydos JC. Emergence of adenovirus type 14 in US military recruits\u2013a new challenge. J Infect Dis. 2007;196(10):1436\u20137.","journal-title":"J Infect Dis"},{"issue":"8","key":"2491_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1749-6632.1957.tb46049.x","volume":"67","author":"MR Hilleman","year":"1957","unstructured":"Hilleman MR. Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci. 1957;67(8):262\u201372.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2491_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/124.2.148","volume":"124","author":"FH Top Jr","year":"1971","unstructured":"Top FH Jr., Grossman RA, Bartelloni PJ, Segal HE, Dudding BA, Russell PK, et al. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J Infect Dis. 1971;124(2):148\u201354.","journal-title":"J Infect Dis"},{"issue":"2","key":"2491_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","volume":"124","author":"FH Top Jr","year":"1971","unstructured":"Top FH Jr., Buescher EL, Bancroft WH, Russell PK. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis. 1971;124(2):155\u201360.","journal-title":"J Infect Dis"},{"issue":"3","key":"2491_CR30","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1086\/313999","volume":"31","author":"GC Gray","year":"2000","unstructured":"Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA, et al. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. For the Adenovirus Surveillance Group. Clin Infect Dis. 2000;31(3):663\u201370.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"2491_CR31","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","volume":"24","author":"KL Russell","year":"2006","unstructured":"Russell KL, Hawksworth AW, Ryan MA, Strickler J, Irvine M, Hansen CJ, et al. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999\u20132004. Vaccine. 2006;24(15):2835\u201342.","journal-title":"Vaccine"},{"issue":"7","key":"2491_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/cid\/ciu507","volume":"59","author":"JM Radin","year":"2014","unstructured":"Radin JM, Hawksworth AW, Blair PJ, Faix DJ, Raman R, Russell KL, et al. Dramatic decline of respiratory illness among US military recruits after the renewed use of adenovirus vaccines. Clin Infect Dis. 2014;59(7):962\u20138.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2491_CR33","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00430-019-00645-2","volume":"209","author":"AC Stasiak","year":"2020","unstructured":"Stasiak AC, Stehle T. Human adenovirus binding to host cell receptors: a structural view. Med Microbiol Immunol. 2020;209(3):325\u201333.","journal-title":"Med Microbiol Immunol"},{"issue":"24","key":"2491_CR34","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","volume":"76","author":"H Wu","year":"2002","unstructured":"Wu H, Dmitriev I, Kashentseva E, Seki T, Wang M, Curiel DT. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. J Virol. 2002;76(24):12775\u201382.","journal-title":"J Virol"},{"issue":"11","key":"2491_CR35","doi-asserted-by":"publisher","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","volume":"174","author":"SM Sumida","year":"2005","unstructured":"Sumida SM, Truitt DM, Lemckert AA, Vogels R, Custers JH, Addo MM, et al. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol. 2005;174(11):7179\u201385.","journal-title":"J Immunol"},{"issue":"1\u20132","key":"2491_CR36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","volume":"160","author":"X Tian","year":"2011","unstructured":"Tian X, Su X, Li H, Li X, Zhou Z, Liu W, et al. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Virus Res. 2011;160(1\u20132):214\u201320.","journal-title":"Virus Res"},{"issue":"10","key":"2491_CR37","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.3390\/v7102896","volume":"7","author":"X Tian","year":"2015","unstructured":"Tian X, Ma Q, Jiang Z, Huang J, Liu Q, Lu X, et al. Identification and application of neutralizing epitopes of human adenovirus type 55 Hexon Protein. Viruses. 2015;7(10):5632\u201342.","journal-title":"Viruses"},{"issue":"16","key":"2491_CR38","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.vaccine.2018.02.050","volume":"36","author":"T Liu","year":"2018","unstructured":"Liu T, Zhou Z, Tian X, Liu W, Xu D, Fan Y, et al. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55. Vaccine. 2018;36(16):2199\u2013206.","journal-title":"Vaccine"},{"key":"2491_CR39","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.virol.2018.03.002","volume":"518","author":"Y Feng","year":"2018","unstructured":"Feng Y, Sun X, Ye X, Feng Y, Wang J, Zheng X, et al. Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity. Virology. 2018;518:272\u201383.","journal-title":"Virology"},{"issue":"7","key":"2491_CR40","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol Biol Evol. 2021;38(7):3022\u20137.","journal-title":"Mol Biol Evol"},{"issue":"30","key":"2491_CR41","doi-asserted-by":"publisher","first-page":"11030","DOI":"10.1073\/pnas.0404206101","volume":"101","author":"K Tamura","year":"2004","unstructured":"Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A. 2004;101(30):11030\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"2491_CR42","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","volume":"26","author":"A Lyons","year":"2008","unstructured":"Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, et al. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine. 2008;26(23):2890\u20138.","journal-title":"Vaccine"},{"issue":"1","key":"2491_CR43","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/infdis\/119.1.51","volume":"119","author":"ED Stanley","year":"1969","unstructured":"Stanley ED, Jackson GG. Spread of enteric live adenovirus type 4 vaccine in married couples. J Infect Dis. 1969;119(1):51\u20139.","journal-title":"J Infect Dis"},{"issue":"Pt 2","key":"2491_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1099\/vir.0.83057-0","volume":"89","author":"AN Lukashev","year":"2008","unstructured":"Lukashev AN, Ivanova OE, Eremeeva TP, Iggo RD. Evidence of frequent recombination among human adenoviruses. J Gen Virol. 2008;89(Pt 2):380\u20138.","journal-title":"J Gen Virol"},{"issue":"3","key":"2491_CR45","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1093\/cid\/cit684","volume":"58","author":"LG Rubin","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44\u2013100.","journal-title":"Clin Infect Dis"},{"key":"2491_CR46","doi-asserted-by":"crossref","unstructured":"Feng Y, Yi C, Liu X, Qu L, Su W, Shu T, et al. Human desmoglein-2 and human CD46 mediate human adenovirus type 55 infection, but human desmoglein-2 plays the major roles. J Virol. 2020;94(17):e00747-20.","DOI":"10.1128\/JVI.00747-20"}],"updated-by":[{"DOI":"10.1186\/s12985-026-03209-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000}}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02491-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02491-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:03:10Z","timestamp":1780581790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-024-02491-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2491"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02491-y","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Fig. 6 appeared incorrectly and have now been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12985-026-03209-y","URL":"https:\/\/doi.org\/10.1186\/s12985-026-03209-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of International Vaccine Institute.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"220"}}